MolecularImaging, June 12th, Lisa Fratt reported on findings of the importance of using PET/CT and MRI to predict the ability of chemotherapy to prolong the life of breast cancer patients.

“The combination of PET and MR imaging data can provide physicians with information on the effectiveness of chemotherapy prior to surgery, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver.”